Alan Sutton

Title: Alan Sutton: Innovator in Cannabidiol Research

Introduction

Alan Sutton, a prominent inventor based in Salisbury, GB, has made significant contributions to the field of cannabinoid research. With a total of four patents, his work focuses primarily on cannabidiol (CBD) and its applications in treating various diseases and disorders.

Latest Patents

Alan's latest patent, titled "Cannabidiol preparations and its uses," highlights the unique formulations of CBD derived from botanical sources. The chemical compound, known as 2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol, features an empirical formula of C21H30O2 and a molecular weight of 314.46. Notably, this invention emphasizes that CBD preparations from botanical origins demonstrate enhanced effectiveness compared to synthetic or overly purified versions, which often lack the beneficial impurities found in natural sources. Surprising insights indicate that the absence of these minor impurities can diminish CBD's therapeutic efficacy.

Career Highlights

Alan has built his expertise while working with notable companies in the pharmaceutical industry, including GW Pharma Limited and Otsuka Pharmaceutical Company, Limited. His research has paved the way for advancements in cannabinoid therapies.

Collaborations

Throughout his career, Alan has collaborated with esteemed colleagues in the field, such as Geoffrey W Guy and Daniela Parolaro. These partnerships have bolstered the innovation process, facilitating breakthroughs in cannabinoid research and applications.

Conclusion

Alan Sutton's work in developing effective cannabidiol preparations highlights his dedication to advancing cannabinoid therapies. His innovative approaches and collaborations have not only contributed to the scientific community but also opened avenues for enhanced treatment options for various health conditions.